| __timestamp | Taro Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 91733000 | 5078000000 |
| Thursday, January 1, 2015 | 87644000 | 4717000000 |
| Friday, January 1, 2016 | 92365000 | 5096000000 |
| Sunday, January 1, 2017 | 85656000 | 4986000000 |
| Monday, January 1, 2018 | 88196000 | 4214000000 |
| Tuesday, January 1, 2019 | 89971000 | 3806000000 |
| Wednesday, January 1, 2020 | 93413000 | 3671000000 |
| Friday, January 1, 2021 | 91355000 | 3528000000 |
| Saturday, January 1, 2022 | 113676000 | 3445000000 |
| Sunday, January 1, 2023 | 198366000 | 3498000000 |
| Monday, January 1, 2024 | 218935000 | 3702000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. This analysis compares the SG&A expenses of Teva Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. from 2014 to 2023.
Teva, a global leader, consistently reported higher SG&A expenses, peaking at approximately $5 billion in 2014. However, by 2023, these expenses had decreased by about 31%, reflecting strategic cost management. In contrast, Taro, a smaller player, saw its SG&A expenses nearly double, from around $91 million in 2014 to $219 million in 2023, indicating potential expansion or increased operational costs.
This divergence highlights the different strategies and challenges faced by these companies in a rapidly evolving industry. Notably, data for Teva in 2024 is missing, suggesting ongoing financial adjustments.
Teva Pharmaceutical Industries Limited vs Biogen Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Intra-Cellular Therapies, Inc.
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Genmab A/S
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
SG&A Efficiency Analysis: Comparing Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S
Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs HUTCHMED (China) Limited
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
United Therapeutics Corporation or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Catalent, Inc. and Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?